Varithena 3 rd February 2015

Save this PDF as:

Size: px
Start display at page:

Download "Varithena 3 rd February 2015"

Transcription

1 Varithena 3 rd February 2015

2 Forward-looking statement This presentation and information communicated verbally to you may contain certain projections and other forward-looking statements with respect to the financial condition, results of operations, businesses and prospects of BTG plc ( BTG ). These statements are based on current expectations and involve risk and uncertainty because they relate to events and depend upon circumstances that may or may not occur in the future. There are a number of factors which could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Any of the assumptions underlying these forward-looking statements could prove inaccurate or incorrect and therefore any results contemplated in the forward-looking statements may not actually be achieved. Nothing contained in this presentation or communicated verbally should be construed as a profit forecast or profit estimate. Investors or other recipients are cautioned not to place undue reliance on any forward-looking statements contained herein. BTG undertakes no obligation to update or revise (publicly or otherwise) any forward-looking statement, whether as a result of new information, future events or other circumstances. Neither this presentation nor any verbal communication shall constitute an invitation or inducement to any person to subscribe for or otherwise acquire securities in BTG. 2

3 Introductions Paul McCubbin Head of Interventional Vascular Greg Walsh General Manager Varithena Phill Keefe Product development and LCM Director Varithena is a registered trademark of Provensis Ltd, a BTG International group company BTG and the BTG roundel logo are registered trademarks of BTG International Ltd 3

4 What are varicose veins? Veins in the legs that are Superficial and raised Dilated, tortuous, elongated Different than spider veins Caused by Failed valves in the vein (GSV) High hydrostatic pressure Time and age They are Symptomatic (aching, throbbing, itching, swelling, disabling) Unsightly Progressive Can cause Itching, pain, eczema Skin damage, ulcers 4

5 CEAP Classification of Chronic Venous Disease of the Leg C 1 telangiectasia C 2-4 varicose veins C 4 lipodermatosclerosis C 6 venous ulceration C 1 : Telangiectasia C 2 : Varicose veins C 4 : Lipodermatosclerosis or hyperpigmentation C 6 : Active ulcer CEAP Classification C 0 : No venous disease C 3 : Edema C 5 : Healed ulcer CEAP = clinical, etiology, anatomy, pathophysiology classification of venous disorders. Bergan et al. N Engl J Med. 2006;355:488. 5

6 Varicose Veins (Superficial Venous Incompetence) are not just a cosmetic condition My legs ache. They just throb and they ache the only relief I get is to hang them straight up in the air Not that I want to show you my ankle right now but it will swell to like three times its regular size because everything just collects there I ve scaled back on exercising because they do feel heavy and tired. And then this one leg has the worse veins in it, throbbing and the pain Well for me it s the itching. that hot, itchy kind of bugs under the skin kind of feeling 6

7 Varicose Veins US Market data* 1.4m people saw a vein specialist in m people symptomatic hence likely to be eligible for reimbursement 0.5m people had treatment, representing approximately 750k GSV procedures Reasons for dropping out include not liking treatment options, vein anatomy and out-of-pocket cost is too high Significant opportunity for a patientcentric treatment option Prevalence: ~30m US incidence 2.5m Incidence: ~2.5m Visited vein Incidence: clinic: BTG 2013 ~1.4m ~2.5 m sales ~$90m Treated: Estimated growth rate ~8% Estimated GSV procedures 2021 ~0.5m GSV Procedures 2012: ~0.75 m Peak sales potential US reimbursed sector Potential including indication expansion and ex-us markets 1.25m $250m $500m+ *BTG estimates based on available reports and proprietary market research 7

8 Treatment of Varicose Veins Visible varicosities 1,2 (GSV tributaries) Ambulatory phlebectomy Liquid/PCF sclerotherapy Varithena Above knee 1,2 (Proximal GSV) Stripping and ligation Endovenous thermal ablation Varithena Below knee 1,2 (Distal GSV) PCF sclerotherapy Some endovenous thermal ablation Varithena Primary cause of symptoms GSV = great saphenous vein; PCF = physician-compounded foam. 1. Draft Prescribing Information. 01/2013; 2. Gloviczki et al J Vasc Surg. 2011;53(suppl 5):2S. 8

9 9

10 The Compelling Varithena Story We are Telling FDA-approved, comprehensive treatment for GSV system incompetence Treats a wide range of vein diameters and anatomies No tumescent anesthesia Cohesive, low-nitrogen foam for consistent performance Novel efficacy endpoints in clinical trials including patient symptoms and appearance Safety evaluated in 1,333 patients in 12 clinical trials Support provided by BTG to help clinicians integrate Varithena into their clinical practice Varithena Solutions Center Varithena Solutions Center is a trademark of Provensis Ltd, a BTG International group company 10

11 So how are we going to be successful? A fully integrated customer centric approach fully supporting our customers We have made conscious choices and investments to ensure the right customer experience 11

12 Embracing the customer KPI s No disappointed legs Go slow to go fast PRO Clinical End points and studies Field team configuration CRM systems & account planning (Left hand right hand) Customer Market access & medical Physician training Payer advocacy SD and SP distribution Varithena Solutions Center HEOR data 12

13 Executing our controlled Varithena US launch Sales Force commenced selling in August and have qualified 1k accounts Prioritising high-volume clinicians with strong interest in using Varithena as a comprehensive treatment Physician qualification process involves online training, video review, patient evaluations Reimbursement support provided Objective is to ensure a great physician and patient experience every time 13

14 Is it working? First patients treated. Positive early signs Great feedback Varithena will simplify the treatment of varicose veins Nicos Labropoulos, PhD Stony Brook's Non-Invasive Vascular Laboratory, NY We achieved a flush and complete ablation of the vessel. In this particular patient, with a history of SVT*, other interventional options were limited. I think this is a tremendous advantage for Varithena and a coup for the entire BTG team Kenneth L. Todd III, MD Southeast Vein and Laser Center, Alabama Varithena will have a significant positive impact in our practice in multiple ways. Tony Gasparis, MD Stony Brook Vein Center, NY 14

15 Varithena US reimbursement Drug reimbursed through a interim J code: Launched as a multi-treatment canister at $3,195 for 45ml usable foam per label i.e. $71 per ml Reimbursed to the physician at upwards of ASP plus 6% Procedure reimbursed under interim CPT code: Work effort and practise expense are near equivalent to Endothermal Ablation (ETA). This is reflected in claims payment successes where reimbursement has been substantially equivalent. Physician Revenue detail GSV ~10mls Comprehensive Leg ~15mls J-code - Drug ~(ASP + 6%) $753 $1,129 CPT code Procedure Comparable to ETA (via crosswalk) Comparable to ETA (via crosswalk) 15

16 Varithena indication and geographic expansion Additional indications US aesthetic market, potential 2017 launch Other venous indications in development RoW markets Leveraging NDA approval Planning a sequenced rollout based on market readiness First approvals potential 2015/16 16

17 Thank you 17

Jefferies 2014 Global Healthcare Conference November Because people depend on us

Jefferies 2014 Global Healthcare Conference November Because people depend on us Jefferies 2014 Global Healthcare Conference November 2014 Because people depend on us Forward-looking statements This presentation and information communicated verbally to you may contain certain projections

More information

EKOS. Interventional Vascular 3 February, Imagine where we can go.

EKOS. Interventional Vascular 3 February, Imagine where we can go. EKOS Interventional Vascular 3 February, 2015 Imagine where we can go. Forward-looking statement This presentation and information communicated verbally to you may contain certain projections and other

More information

Clinical/Duplex Evaluation of Varicose Veins: Who to Treat?

Clinical/Duplex Evaluation of Varicose Veins: Who to Treat? Clinical/Duplex Evaluation of Varicose Veins: Who to Treat? Sanjoy Kundu MD, FASA, FCIRSE, FSIR The Vein Institute of Toronto Scarborough Vascular Group Scarborough Vascular Ultrasound Scarborough Vascular

More information

Chronic Venous Insufficiency Compression and Beyond

Chronic Venous Insufficiency Compression and Beyond Disclosure of Conflict of Interest Chronic Venous Insufficiency Compression and Beyond Shawn Amyot, MD, CCFP Fellow of the Canadian Society of Phlebology Ottawa Vein Centre I do not have relevant financial

More information

Additional Information S-55

Additional Information S-55 Additional Information S-55 Network providers are encouraged, but not required to participate in the on-line American Venous Forum Registry (AVR) - The First National Registry for the Treatment of Varicose

More information

Patient assessment and strategy making for endovenous treatment

Patient assessment and strategy making for endovenous treatment Patient assessment and strategy making for endovenous treatment Raghu Kolluri, MD Director Vascular Medicine OhioHealth Riverside Methodist Hospital Columbus, OH Disclosures Current Medtronic Consultant/

More information

COMMISSIONING POLICY

COMMISSIONING POLICY Ref No. 1a7.5 COMMISSIONING POLICY Surgery for venous disease of the leg (Varicosities of the Long Saphenous Vein) April 2011 CONTENTS Section Page Summary 2 1. Background 2 2. Criteria for eligibility

More information

Medicare C/D Medical Coverage Policy

Medicare C/D Medical Coverage Policy Varicose Vein Treatment Medicare C/D Medical Coverage Policy Origination Date: June 1, 1993 Review Date: February 15, 2017 Next Review: February, 2019 DESCRIPTION OF PROCEDURE OR SERVICE Varicose veins

More information

Conflict of Interest. None

Conflict of Interest. None Conflict of Interest None American Venous Forum Guidelines on Superficial Venous Disease TOP 10 GUIDELINES 10. We recommend using the CEAP classification to describe chronic venous disorders. (GRADE 1B)

More information

Priorities Forum Statement

Priorities Forum Statement Priorities Forum Statement Number 9 Subject Varicose Vein Surgery Date of decision September 2014 Date refreshed March 2017 Date of review September 2018 Relevant OPCS codes: L841-46, L848-49, L851-53,

More information

Focusing our energy on saving lives

Focusing our energy on saving lives October 2017 The Outlook for Oncology: The Shrinking, Affordable Proton Therapy Center Focusing our energy on saving lives Jonathan Farr, DSc Senior Vice President Medical Physics Forward Looking Statement

More information

PROVIDER POLICIES & PROCEDURES

PROVIDER POLICIES & PROCEDURES PROVIDER POLICIES & PROCEDURES TREATMENT OF VARICOSE VEINS OF THE LOWER EXTREMITIES STAB PHLEBECTOMY AND SCLEROTHERAPY TREATMENT The primary purpose of this document is to assist providers enrolled in

More information

Segmental GSV reflux

Segmental GSV reflux Segmental GSV reflux History of presentation A 43 year old female presented with right lower extremity varicose veins and swelling. She had symptoms of aching, heaviness and tiredness in the right leg.

More information

Clinical case. Symptomatic anterior accessory great saphenous vein (AAGSV) reflux

Clinical case. Symptomatic anterior accessory great saphenous vein (AAGSV) reflux Clinical case Symptomatic anterior accessory great saphenous vein (AAGSV) reflux A 70 year-old female presents with symptomatic varicose veins on left leg for more than 10 years. She complains of heaviness,

More information

OHTAC Recommendation. Endovascular Laser Treatment for Varicose Veins. Presented to the Ontario Health Technology Advisory Committee in November 2009

OHTAC Recommendation. Endovascular Laser Treatment for Varicose Veins. Presented to the Ontario Health Technology Advisory Committee in November 2009 OHTAC Recommendation Endovascular Laser Treatment for Varicose Veins Presented to the Ontario Health Technology Advisory Committee in November 2009 April 2010 Issue Background The Ontario Health Technology

More information

New Technologies in Superficial Vein Treatment

New Technologies in Superficial Vein Treatment New Technologies in Superficial Vein Treatment Ariel D. Soffer, MD, FACC Associate Clinical Professor Florida International University Medical School Ariel Soffer, MD, FACC Bio Fellow of the American College

More information

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.066.MH Last Review Date: 11/08/2018 Effective Date: 01/01/2019

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.066.MH Last Review Date: 11/08/2018 Effective Date: 01/01/2019 MedStar Health, Inc. POLICY AND PROCEDURE MANUAL This policy applies to the following lines of business: MedStar Employee (Select) MedStar CareFirst PPO MedStar Health considers the treatment of Varicose

More information

Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden

Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden Disclosures No disclosures Five sources for comparison SVS/AVF US guidelines

More information

Criteria For Medicare Members. Kaiser Foundation Health Plan of Washington

Criteria For Medicare Members. Kaiser Foundation Health Plan of Washington Clinical Review Criteria Treatment of Varicose Veins Radiofrequency Catheter Closure Sclerotherapy Surgical Stripping Trivex System for Outpatient Varicose Vein Surgery VenaSeal Closure System VNUS Closure

More information

Patient Information. Venous Insufficiency and Varicose Veins

Patient Information. Venous Insufficiency and Varicose Veins Patient Information Venous Insufficiency and Varicose Veins What is a Varicose Vein? Gitter Vein Institute-revised 3/8/2016 2 Frequently Asked Questions What is the difference between varicose and spider

More information

AMERICAN PODIATRIC MEDICAL ASSOCIATION

AMERICAN PODIATRIC MEDICAL ASSOCIATION AMERICAN PODIATRIC MEDICAL ASSOCIATION THE NATIONAL ANNUAL SCIENTIFIC MEETING Friday, July 13 th 2018 Washington, D.C. CHRONIC VENOUS INSUFFICIENCY OF THE LOWER EXTREMITIES Clinical Pearls for the Podiatrist

More information

Medical Affairs Policy

Medical Affairs Policy Service: Varicose Vein Treatments PUM 250-0032 Medical Affairs Policy Medical Policy Committee Approval 12/01/17 Effective Date 04/01/18 Prior Authorization Needed Yes Disclaimer: This policy is for informational

More information

Recurrent Varicose Veins We All See Them

Recurrent Varicose Veins We All See Them We All See Them November 4, 2017 Austin, TX Arlington Heights, IL No conflicts Terminology REVAS REcurrent Varices After Surgery PREVAIT PREsence of Varices After Interventional Treatment Recurrent varices

More information

Vein Disease Treatment

Vein Disease Treatment MP9241 Covered Service: Yes when meets criteria below Prior Authorization Required: Yes as indicated in 2.0, 3.0, 4.0 and 5.0 Additional Information: None Prevea360 Health Plan Medical Policy: Vein disease

More information

How varicose veins occur

How varicose veins occur Varicose veins are a very common problem, generally appearing as twisting, bulging rope-like cords on the legs, anywhere from groin to ankle. Spider veins are smaller, flatter, red or purple veins closer

More information

Epidemiology: Prevalence

Epidemiology: Prevalence Epidemiology: Prevalence More than 30 million Americans suffer from varicose veins or a more serious form of venous disease called Chronic Venous Insufficiency (CVI). 1 Of the over 30 million Americans

More information

Chronic Venous Insufficiency

Chronic Venous Insufficiency Chronic Venous Insufficiency None Disclosures Lesley Enfinger, MSN,NP-C Chronic Venous Insufficiency Over 24 Million Americans affected by Chronic Venous Insufficiency (CVI) 10 x More Americans suffer

More information

New Guideline in venous ulcer treatment: dressing, medication, intervention

New Guideline in venous ulcer treatment: dressing, medication, intervention New Guideline in venous ulcer treatment: dressing, medication, intervention Kittipan Rerkasem, FRCS(T), PhD Department of Surgery Faculty of Medicine Chiang Mai University Topic Overview venous ulcer treatment

More information

Varicose Veins What Are They? Sclerotherapy in the Treatment of Venous Disease Zachary C. Schmittling, MD, FACS May 4, 2018

Varicose Veins What Are They? Sclerotherapy in the Treatment of Venous Disease Zachary C. Schmittling, MD, FACS May 4, 2018 Sclerotherapy in the Treatment of Venous Disease Zachary C. Schmittling, MD, FACS May 4, 2018 Sclerotherapy for Venous Disease: Overview 1 in 5 Americans Approximately 25% of women have some type of lower

More information

Non-Saphenous Vein Treatments. Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO

Non-Saphenous Vein Treatments. Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO Non-Saphenous Vein Treatments Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO I have no financial disclosures Types of Veins Treated Perforator Veins Tributary Veins Varicose

More information

Venous Disease and Leg Ulcers. Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL

Venous Disease and Leg Ulcers. Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL Venous Disease and Leg Ulcers Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL Disclosures Stocks Endoshape Sapheon Medical Advisory Board BTG, Boston Scientific Venous Leg Ulcer Most common

More information

Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA

Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA DISCLOSURES Kathleen Gibson, MD Consultant/Advisory Board: BTG, Medtronic Speakers

More information

Subject: Treatments for Varicose Veins/Venous Insufficiency

Subject: Treatments for Varicose Veins/Venous Insufficiency 02-33000-31 Original Effective Date: 02/15/02 Reviewed: 08/23/18 Revised: 09/15/18 Subject: Treatments for Varicose Veins/Venous Insufficiency THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION,

More information

Appendix 7c Varicose Veins Task and Finish Group meeting, 3 May 2018 Notes of key discussion points

Appendix 7c Varicose Veins Task and Finish Group meeting, 3 May 2018 Notes of key discussion points Appendix 7c Varicose Veins Task and Finish Group meeting, 3 May 2018 Notes of key discussion points Task and Finish Group members Attendees: Stella Vig Vascular Consultant Surgeon & Clinical SWL Director

More information

Varicose Veins are a Symptom of Vein Disease. Now you can treat the source of your varicose veins with non-surgical endovenous laser treatment.

Varicose Veins are a Symptom of Vein Disease. Now you can treat the source of your varicose veins with non-surgical endovenous laser treatment. Varicose Veins are a Symptom of Vein Disease. Now you can treat the source of your varicose veins with non-surgical endovenous laser treatment. Approximately 1 in 5 adult Americans suffer from superficial

More information

RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY

RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY Paul Kramer, MD, FACC, FSCAI Liberty Cardiovascular Specialists Liberty Regional Heart and Vascular Center DISCLOSURES NONE Venous

More information

Love your legs again Varicose Veins

Love your legs again Varicose Veins Love your legs again Varicose Veins Veins are the vessels that return blood to the heart once it has circulated through the body (as opposed to arteries, which carry oxygen-rich blood from the heart to

More information

Chronic Venous Disease: A Complex Disorder. A N Nicolaides

Chronic Venous Disease: A Complex Disorder. A N Nicolaides Chronic Venous Disease: A Complex Disorder A N Nicolaides Emeritus Professor of Vascular Surgery, Imperial College, London. Hon. Professor of Surgery, University of Nicosia Medical School, Cyprus Disclosures

More information

Selection and work up for the right patients suspected of deep venous disease

Selection and work up for the right patients suspected of deep venous disease Selection and work up for the right patients suspected of deep venous disease R A G H U K O L L U R I, M S, M D, R V T S Y S T E M M E D I C A L D I R E C T O R V A S C U L A R M E D I C I N E / V A S

More information

Determine the patients relative risk of thrombosis. Be confident that you have had a meaningful discussion with the patient.

Determine the patients relative risk of thrombosis. Be confident that you have had a meaningful discussion with the patient. Patient Assessment :Venous History, Examination and Introduction to Doppler and PPG Dr Louis Loizou The 11 th Annual Scientific Meeting and Workshops of the Australasian College of Phlebology Tuesday 18

More information

Current Management of C0s patient

Current Management of C0s patient Current Management of C0s patient M. Perrin Vascular Surgery, Lyon, France 1 AIM of the PRESENTATION - 1 st to estimate the prevalence of C 0s patient - 2 d to evaluate its current management - 3d to suggest

More information

UNDERSTANDING VEIN DISEASE. UC EN - For use in the U.S. only

UNDERSTANDING VEIN DISEASE. UC EN - For use in the U.S. only UNDERSTANDING VEIN DISEASE UC201706537 EN - For use in the U.S. only Do you need to sit down during your work day because your legs ache and/or swell? Do you miss out on doing the activities you love because

More information

Disclosures. What is a Specialty Vein Clinic? Prevalence of Venous Disease. Management of Venous Disease: an evidence based approach.

Disclosures. What is a Specialty Vein Clinic? Prevalence of Venous Disease. Management of Venous Disease: an evidence based approach. Management of Venous Disease: an evidence based approach Disclosures Ed Boyle, MD Andrew Jones, MD Dr. Ed Boyle and Dr. Andrew Jones disclose Grants/research support: Medtronic, BTG International, Clearflow,

More information

Current Management of Varicose Veins

Current Management of Varicose Veins Current Management of Varicose Veins Michael J. Heidenreich, MD St. Joseph Mercy Hospital Ann Arbor, MI March 23, 2013 Nothing to disclose History Prevalence Anatomy Risk factors Clinical manifestations

More information

PHLEBOLOGY. Venous Insufficiency. Presentation Use Information

PHLEBOLOGY. Venous Insufficiency. Presentation Use Information Disclosure of Conflict of Interest THE BASICS OF VENOUS INSUFFICIENCY: What You Should Know. An Introductory Lecture Donald Ives, MD, RVT, RPVI Board Certified Family Physician Diplomate of the American

More information

lipodermatosclerosis standards of medical practitioners and the quality of patient care related to the treatment of venous disorders.

lipodermatosclerosis standards of medical practitioners and the quality of patient care related to the treatment of venous disorders. Chattanooga s premiere VEIN CENTER Update on Venous Insufficiency, Varicose and Spider Veins 2016 Vincent W. Gardner, MD, FACS, RPVI Fellow, American College of Surgeons Board Certified, American Board

More information

Description and Management of C0s patient. M. Perrin, Vascular Surgery, Lyon, France

Description and Management of C0s patient. M. Perrin, Vascular Surgery, Lyon, France Description and Management of C0s patient M. Perrin, Vascular Surgery, Lyon, France 1 No disclosure of interest to declare for this presentation 2 AIM of the PRESENTATION 1 st to estimate the prevalence

More information

Mindful Reflections On The Management. of Venous Ulceration. Presenter name. Title Date

Mindful Reflections On The Management. of Venous Ulceration. Presenter name. Title Date C Scott McEnroe, MD, FACS Medical Director Vein Center of Virginia Sentara Vascular Specialists April 25 th, 2014 Mindful Reflections On The Management of Venous Ulceration Approximately 97 % of all statistics

More information

Treatment of Varicose Veins/Venous Insufficiency

Treatment of Varicose Veins/Venous Insufficiency MEDICAL POLICY 7.01.519 Treatment of Varicose Veins/Venous Insufficiency BCBSA Ref. Policy: 7.01.124 Effective Date: March 1, 2017 Last Revised: Jan. 23, 2018 Replaces: 7.01.55, 7.01.76, 7.01.515, and

More information

CoolTouchCTEV. Endovenous 1320nm Laser Treatment for Varicose Veins

CoolTouchCTEV. Endovenous 1320nm Laser Treatment for Varicose Veins CoolTouchCTEV Endovenous 1320nm Laser Treatment for Varicose Veins 99% EFFICACY Science. Results. Trust. 99% efficacy rate short procedure time fewer risks and complications than vein stripping ideal outpatient

More information

How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN.

How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN. How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN Surgeon Dr G Mark Malouf Sydney Australia Following History and Physical examination

More information

N.S. Theivacumar, R.J. Darwood, M.J. Gough*

N.S. Theivacumar, R.J. Darwood, M.J. Gough* Eur J Vasc Endovasc Surg (2009) 37, 477e481 Endovenous Laser Ablation (EVLA) of the Anterior Accessory Great Saphenous Vein (): Abolition of Sapheno-Femoral Reflux with Preservation of the Great Saphenous

More information

Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue)

Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue) Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue) Awais Siddique MD Endovascular Radiologist AZH WAVE CENTERS Milwaukee WI Venous disease Etiology Are the result of Venous valvular

More information

Treatment of Varicose Veins/Venous Insufficiency. Description

Treatment of Varicose Veins/Venous Insufficiency. Description Page: 1 of 24 Last Review Status/Date: March 2015 Description A variety of treatment modalities are available to treat varicose veins/venous insufficiency, including surgical approaches, thermal ablation,

More information

Dr Paul Thibault. Phlebologist & Assistant Editor Phlebology (International Journal) Australasian College of Phlebology

Dr Paul Thibault. Phlebologist & Assistant Editor Phlebology (International Journal) Australasian College of Phlebology Dr Paul Thibault Phlebologist & Assistant Editor Phlebology (International Journal) Australasian College of Phlebology Prescribing Effective Compression and PTS Dr Paul Thibault Phlebologist, Newcastle,

More information

INVESTOR PRESENTATION

INVESTOR PRESENTATION INVESTOR PRESENTATION May 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities regulation.

More information

Prospective evaluation of endo venous laser therapy for varicose vein; early efficacy and complications. The first report from Iran

Prospective evaluation of endo venous laser therapy for varicose vein; early efficacy and complications. The first report from Iran Iran. J. Radiat. Res., 2006; 4 (2): 87-91 Prospective evaluation of endo venous laser therapy for varicose vein; early efficacy and complications. The first report from Iran J. Salimi 1*, F.Yourdkhani

More information

Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015

Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015 Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015 Anatomy of Perforating veins Cadaveric studies 1 have shown >60 vein perforating veins from superficial to deep Normal

More information

SAVE LIMBS SAVE LIVES! Endovenous Ablation for Chronic Wounds

SAVE LIMBS SAVE LIVES! Endovenous Ablation for Chronic Wounds SAVE LIMBS SAVE LIVES! Endovenous Ablation for Chronic Wounds Frank J. Tursi, DPM, FACFS Clinical Associate Professor, University of Pennsylvania/Presbyterian Foot and Ankle Consultant, Philadelphia Flyers,

More information

Prevalence. Definition. Chronic Venous Insufficiency. Overview of Chronic Venous Insufficiency

Prevalence. Definition. Chronic Venous Insufficiency. Overview of Chronic Venous Insufficiency Overview of Chronic Venous Insufficiency Steven M. Dean, DO, FACP, RPVI Vascular Medicine Specialist Assistant Professor of Internal Medicine Department of Cardiovascular Medicine The Ohio State University

More information

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician:

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician: E S Insurance: 2 nd Insurance: Wait time: Date: A. Venous Health History Form Patient please complete questions 1-12 Patient Name: SSN#: Date of Birth: Primary Care Physician: What is the reason for your

More information

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician:

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician: E S Insurance: 2 nd Insurance: Wait time: Date: A. Venous Health History Form Patient please complete questions 1-12 Patient Name: SSN#: Date of Birth: Primary Care Physician: What is the reason for your

More information

Treatment of Varicose Veins

Treatment of Varicose Veins Treatment of Varicose Veins Policy Number: Original Effective Date: MM.06.016 04/15/2005 Line(s) of Business: Current Effective Date: PPO; HMO; QUEST Integration 09/28/2018 Section: Surgery Place(s) of

More information

Investor Presentation

Investor Presentation Investor Presentation February 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities

More information

V I U R E V I E W. T h e O f f i c i a l J o u r n a l o f V e n o u s I n s u f f i c i e n c y U n i v e r s i t y

V I U R E V I E W. T h e O f f i c i a l J o u r n a l o f V e n o u s I n s u f f i c i e n c y U n i v e r s i t y C o m p l i m e n t s o f S a n j i v L a k h a n p a l, M D, J a i m e M a r q u e z, M D, J e r r i l y n J u t t o n, M D, K e l l y O ' D o n n e l l, M D, R a j i v J h a v e r i, M D, L u i s A.

More information

Varicose Vein Surgery

Varicose Vein Surgery What are varicose veins? Varicose veins are enlarged and twisted veins in your leg. Varicose veins are common, affecting up to 3 in 10 people. Varicose veins tend to run in families and are made worse

More information

FIND RELIEF FROM VARICOSE VEINS. VenaSeal Sapheon Closure System

FIND RELIEF FROM VARICOSE VEINS. VenaSeal Sapheon Closure System FIND RELIEF FROM VARICOSE VEINS VenaSeal Sapheon Closure System UNDERSTAND Varicose veins may be a sign of something more severe. Your doctor can help you understand if you have this condition. may cause

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Varicose Veins of the Lower Extremities, Treatment for File Name: Origination: Last CAP Review: Next CAP Review: Last Review: varicose_veins_of_the_lower_extremities_treatment_for

More information

Medical Policy. Description/Scope. Position Statement

Medical Policy. Description/Scope. Position Statement Subject: Document #: Publish Date: 12/27/2017 Status: Revised Last Review Date: 05/04/2017 Description/Scope This document addresses various modalities (listed below) for the treatment of valvular incompetence

More information

The Vascular Disease Almost No One Teaches But Should!!! Chronic Venous Insufficiency

The Vascular Disease Almost No One Teaches But Should!!! Chronic Venous Insufficiency The Vascular Disease Almost No One Teaches But Should!!! Chronic Venous Insufficiency Thomas E. Eidson, DO Certified Venous Disease Specialist Board Certified Family Medicine Disclosure of Conflict of

More information

Why Tumescent-Free Therapy Will Replace RF and Laser

Why Tumescent-Free Therapy Will Replace RF and Laser C SCOTT MCENROE Medical Director Vein Center of Virginia Sentara Medical Group April 27, 2018 Why Tumescent-Free Therapy Will Replace RF and Laser History of Venous Surgery 1950 s GSV/SSV stripping became

More information

TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY

TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY TL LUK Consultant Vascular Surgeon Sarawak General Hospital HKL Vascular Conference 19/06/2013 PREVALENCE OF LOWER LIMB VENOUS DISEASE Affects half of

More information

Surgery or combined endolaser ablation and sclerotherapy for varicose veins, a new trend in a developing country (Iraq); a cohort study

Surgery or combined endolaser ablation and sclerotherapy for varicose veins, a new trend in a developing country (Iraq); a cohort study Surgery or combined endolaser ablation and sclerotherapy for varicose veins, a new trend in a developing country (Iraq); a cohort study Bashar Hanna Azar (1) Ashur Yohanna Izac Oraha (2) Emad Abdulrahman

More information

Dr Peter Chapman-Smith

Dr Peter Chapman-Smith Dr Peter Chapman-Smith Phlebologist NZ Stem Cell Treatment Centre, Whangarei 12:00-12:30 Healing Those Heartsink Leg Ulcers Healing Those Heartsink Leg Ulcers Practice Nurses Presentation GPCME Christchurch

More information

Healthy Never Looked So Good. At the forefront of the latest solutions in vein treatment.

Healthy Never Looked So Good. At the forefront of the latest solutions in vein treatment. Healthy Never Looked So Good. At the forefront of the latest solutions in vein treatment. The Vein Institute team of secretaries, technicians, nurses, and Dr. Alex Afshar treated my vein issues with care

More information

Original Policy Date

Original Policy Date MP 7.01.104 Treatment of Varicose Veins Medical Policy Section Surgery Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date Local policy/12/2013 Return to Medical Policy Index Disclaimer

More information

Le varici recidive Recurrent varices: how to manage them?

Le varici recidive Recurrent varices: how to manage them? Le varici recidive Recurrent varices: how to manage them? Marianne De Maeseneer MD PhD, Vascular Surgeon Department of Dermatology, Rotterdam, Netherlands & Faculty of Medicine and Health Sciences University

More information

Clinical Policy Title: Varicose vein treatments

Clinical Policy Title: Varicose vein treatments Clinical Policy Title: Varicose vein treatments Clinical Policy Number: CCP.1131 Effective Date: January 1, 2014 Initial Review Date: August 20, 2014 Most Recent Review Date: August 30, 2018 Next Review

More information

Clinical Policy Title: Varicose vein treatments

Clinical Policy Title: Varicose vein treatments Clinical Policy Title: Varicose vein treatments Clinical Policy Number: CCP.1131 Effective Date: January 1, 2014 Initial Review Date: August 20, 2014 Most Recent Review Date: August 30, 2018 Next Review

More information

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Varicose Veins Page 1 of 29 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: Varicose Veins Professional Institutional Original Effective Date: January 1, 2004

More information

Varicose veins. Information for patients Sheffield Vascular Institute

Varicose veins. Information for patients Sheffield Vascular Institute Varicose veins Information for patients Sheffield Vascular Institute You have been diagnosed as having varicose veins. This leaflet explains more about varicose veins and answers some of the most frequently

More information

MOCA and GLUE: results and analyses of the RCTs

MOCA and GLUE: results and analyses of the RCTs MOCA and GLUE: results and analyses of the RCTs Faculty disclosure Research Grant Medtronic Educational Grant mediusa Speakers Bureau Medtronic Pierre Fabre mediusa Medical Director Morrison Vein/Training

More information

Venous Care Partnership

Venous Care Partnership Venous Care Partnership Working collaboratively to ensure appropriate care for our patients August 3, 2016 Aysegul Gozu, MD, MPH Elise Berliner, PhD Task Order Officers Center for Evidence and Practice

More information

Endo-Thermal Heat Induced Thrombosis (E-HIT)

Endo-Thermal Heat Induced Thrombosis (E-HIT) Endo-Thermal Heat Induced Thrombosis (E-HIT) Michael Ombrellino MD FACS The Cardiovascular Care Group Clinical Associate Professor of Surgery Rutgers School of Medicine Objectives: What is E-HIT? How do

More information

RADIOFREQUENCY ABLATION. Professor M Baguneid MB ChB MD FRCS

RADIOFREQUENCY ABLATION. Professor M Baguneid MB ChB MD FRCS RADIOFREQUENCY ABLATION This minimally invasive treatment involves closing the faulty veins using a keyhole approach thereby avoiding the larger cuts and avoiding stripping of the veins. Professor M Baguneid

More information

Interactive Learning Session

Interactive Learning Session Chronic Venous Disease - Part I Interactive Learning Session 2011 Ali Sabbour Prof of Vascular Surgery http://mic.shams.edu.eg/moodle6 Login as a guest Surgery 2 Ali Sabbour - Chronic Venous Disease Intended

More information

Revolutionizing how advanced heart disease is treated

Revolutionizing how advanced heart disease is treated LEERINK Partners 5th Annual Healthcare Conference Revolutionizing how advanced heart disease is treated NASDAQ: NCVN, TSX: NVC Alexei Marko, CEO February 2016 Forward-Looking Statements Statements contained

More information

- Plans Commercial Launch of three dosing options for Excellagen in pre-filled syringes

- Plans Commercial Launch of three dosing options for Excellagen in pre-filled syringes Generex Biotechnology Subsidiary Olaregen Therapeutix Inc. Plans Launch of FDA Cleared Excellagen Wound Conforming Gel Matrix with Three Dosage Options - Plans Commercial Launch of three dosing options

More information

Varicose veins. Natural history, assessment and management. Arteries and veins. Why do people get varicose veins? Classification of venous disease

Varicose veins. Natural history, assessment and management. Arteries and veins. Why do people get varicose veins? Classification of venous disease Arteries and veins Neil Wright Rob Fitridge Varicose veins Natural history, assessment and management Background Varicose veins are a common condition. Presentations can range from those that are noticed

More information

Occasional pain or other discomfort (ie, not restricting regular daily activity)

Occasional pain or other discomfort (ie, not restricting regular daily activity) Revised Venous Clinical Severity Score Pain : 0 Mild: 1 or other discomfort (ie, aching, heaviness, fatigue, soreness, burning) Occasional pain or other discomfort (ie, not restricting regular daily activity)

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Varicose Veins Page 1 of 37 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Varicose Veins Professional Institutional Original Effective Date: January 1, 2004 Original

More information

Endovenous Laser Therapy INFORMATION & TREATMENT INSTRUCTIONS

Endovenous Laser Therapy INFORMATION & TREATMENT INSTRUCTIONS 1324 Princess Street Kingston, ON K7M 3E2 Website: www.ucosmetic.com Email: nuyu@ucosmetic.com Phone: (613) 536-LASR (5277) Fax: (613) 536-5108 Dr. Kim Meathrel, MD, FRCSC, Plastic Surgeon, Associate Professor

More information

Treatment of Varicose Veins/Venous Insufficiency Corporate Medical Policy

Treatment of Varicose Veins/Venous Insufficiency Corporate Medical Policy Treatment of Varicose Veins/Venous Insufficiency Corporate Medical Policy File name: Treatment of Varicose Veins/Venous Insufficiency File code: UM.SURG.03 Origination: 9/01/2010 Last Review: 03/2015 Next

More information

Treatment of Varicose Veins/Venous Insufficiency

Treatment of Varicose Veins/Venous Insufficiency Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

o Self-Contained & Disposable: Fully self-contained, single-use device with no need for capital equipment purchase

o Self-Contained & Disposable: Fully self-contained, single-use device with no need for capital equipment purchase The ClariVein OC Proprietary dual action device^ ClariVein OC is a specialty catheter for the infusion of physician-specified agents in the peripheral vasculature including for endovascular occlusion of

More information

USPSTF Draft Recommendations Investor Call. October 6, 2015

USPSTF Draft Recommendations Investor Call. October 6, 2015 USPSTF Draft Recommendations Investor Call October 6, 2015 v Safe Harbor Statement Certain statements made in this presentation contain forward-looking statements within the meaning of Section 27A of the

More information

BlueCross BlueShield of Tennessee Medical Policy Manual

BlueCross BlueShield of Tennessee Medical Policy Manual Varicose Vein Treatments for the Lower Extremities DESCRIPTION BlueCross BlueShield of Tennessee Medical Policy Manual Varicose veins, enlarged, dilated, and tortuous vessels are a common clinical manifestation

More information

Diagnostics for the early detection and prevention of colon cancer. Leerink Swann Global Health Care Conference February 2015

Diagnostics for the early detection and prevention of colon cancer. Leerink Swann Global Health Care Conference February 2015 Diagnostics for the early detection and prevention of colon cancer Leerink Swann Global Health Care Conference February 2015 Safe Harbor Statement Certain statements made in this news release contain forward-looking

More information

Varicose Vein Cyanoacrylate Glue treatment

Varicose Vein Cyanoacrylate Glue treatment The South West s premier independent healthcare and cosmetic clinic Varicose Vein Cyanoacrylate Glue treatment Varicose veins are a sign of underlying venous insufficiency and affect 20 30% of adults.

More information